[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100625987":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":23,"centralContacts":24,"locations":31,"responsibleParty":47,"collaborators":23,"id":49,"slug":50,"hasResults":51,"nctId":52,"briefTitle":53,"officialTitle":53,"acronym":54,"eligibilityCriteria":55,"healthyVolunteers":51,"sex":56,"minAge":57,"maxAge":58,"enrollmentInfo":59,"targetDuration":23,"studyType":62,"phases":63,"briefSummary":65,"conditions":66,"keywords":69,"overallStatus":71,"whyStopped":23,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":76,"completionDateStruct":78,"leadSponsor":80,"locationsCount":81},{"fullName":5,"class":6},"Centre Hospitalier Universitaire de Nice","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Group 1 : Patients with pelvic pain","EXPERIMENTAL","Patients with chronic pelvic pain resistant to hormone therapy",[13],"Other: Immune profile",{"label":15,"type":10,"description":16,"interventionNames":17},"Group 2 : Asymptomatic patients","Asymptomatic patients undergoing hormone therapy",[13],[19],{"type":6,"name":20,"description":21,"armGroupLabels":22,"otherNames":23},"Immune profile","The immune profile will be determined by measuring blood concentrations (in pg\u002FmL) of pro-inflammatory and anti-inflammatory cytokines measured after non-specific stimulation of peripheral blood cells from each patient: IL4, IL5, IL12p70, 1L17A, IFNγ, IL1β, IL6, IL8, IL10, IL15, IL18, TNFα, TGFβ.",[9,15],null,[25],{"name":26,"role":27,"phone":28,"phoneExt":29,"email":30},"Pierre-Alexis GAUCI, MD","CONTACT","04 92 03 61 90","+33","gauci.pa@chu-nice.fr",[32],{"facility":33,"status":23,"city":34,"state":35,"zip":36,"country":37,"countryCode":38,"cosmosGeoPoint":39,"geoPoint":44,"contacts":45},"CHU Nice - Hôpital de l'Archet 2","Nice","Alpes-Maritimes","06200","France","FR",{"type":40,"coordinates":41},"Point",[42,43],7.26608,43.70313,{"lat":43,"lon":42},[46],{"name":26,"role":27,"phone":28,"phoneExt":29,"email":30},{"type":48,"investigatorFullName":23,"investigatorTitle":23,"investigatorAffiliation":23,"oldNameTitle":23,"oldOrganization":23},"SPONSOR","100625987","identify-a-specific-immune-profile-in-patients-with-chronic-pelvic-pain-resistant-to-first-line-treatments-by-measuring-th1-th2-th17-and-treg-cytokines-produced-after-non-specific-functional-cell-stimulation---immunocpp-100625987",false,"NCT07429773","Identify a Specific Immune Profile in Patients With Chronic Pelvic Pain Resistant to First-line Treatments by Measuring Th1, Th2, Th17, and Treg Cytokines Produced After Non-specific Functional Cell Stimulation - ImmunoCPP","ImmunoCPP","Inclusion Criteria:\n\n1. Aged between 18 and 40;\n2. Under continuous hormone treatment for at least 6 months;\n3. Imaging less than 12 months old: either normal or showing endometriosis and\u002For adenomyosis lesions, excluding any other abnormalities that could explain the PCOS;\n4. Affiliation with the French Social Security system;\n5. Signature of informed consent.\n\nExclusion Criteria:\n\n1. Pregnant or breastfeeding women;\n2. Autoimmune disease;\n3. History of cancer within the last 5 years or currently undergoing treatment;\n4. Current infectious syndrome;\n5. Person under guardianship or conservatorship.","FEMALE","18 Years","40 Years",{"count":60,"type":61},120,"ESTIMATED","INTERVENTIONAL",[64],"NA","Chronic pelvic pain (CPP) affects more than one in four women. An immune imbalance in the Th1\u002FTh2 balance has been reported in multiple CPP situations, particularly in patients with endometriosis, but with mixed results. The use of a functional immune test, already validated in previous indications and particularly in infertility, could simulate an immune stimulation similar to that of painful attacks.",[67,68],"Endometriosis","Chronic Pelvic Pain Syndrome",[67,68,70],"women","NOT_YET_RECRUITING","2026-02-17",{"date":74,"type":75},"2026-02-24","ACTUAL",{"date":77,"type":61},"2026-04",{"date":79,"type":61},"2028-04",{"name":5,"class":6},1]